US 12,227,731 B2
Flow electroporation device
Edward Dai, Suzhou (CN)
Assigned to ETTA BIOTECH CO., LTD., Suzhou (CN)
Appl. No. 16/756,269
Filed by Etta Biotech Co., Ltd., Suzhou (CN)
PCT Filed Oct. 19, 2018, PCT No. PCT/CN2018/110915
§ 371(c)(1), (2) Date Apr. 15, 2020,
PCT Pub. No. WO2019/076353, PCT Pub. Date Apr. 25, 2019.
Claims priority of application No. 201710997572.5 (CN), filed on Oct. 19, 2017.
Prior Publication US 2020/0318055 A1, Oct. 8, 2020
Int. Cl. C12M 1/42 (2006.01); C12M 1/34 (2006.01); C12N 13/00 (2006.01); C12N 15/87 (2006.01); A61N 1/32 (2006.01)
CPC C12M 35/02 (2013.01) [C12M 41/12 (2013.01); C12N 13/00 (2013.01); C12N 15/87 (2013.01); A61N 1/327 (2013.01)] 14 Claims
OG exemplary drawing
 
1. A flow electroporation device comprising:
a bracket;
an electrode device including planar electrodes for subjecting an electric field to flowing viable cells therebetween, the flowing viable cells not being cancer cells, wherein the bracket and the planar electrodes jointly restrict a channel for fluid flow;
wherein a material of the planar electrodes comprises one or more of platinum-plated titanium, molybdenum-plated rhodium, ruthenium-plated rhodium, niobium-plated iridium and iridium-plated platinum;
wherein the bracket has recessed windows, and the planar electrodes are mounted in the recessed windows and encapsulated.